Importantly, individuals with germline PTEN variants had the highest prevalence of cancer compared to the other two groups, including those with germline variants in other cancer predisposition genes (OR, 2.31; 95% CI 1.27–4.14; P=0.007). This evidence concerns the gene PTEN and cancer.